This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Evocatal Gmbh. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Jennifer Andexer: Innovator in Chiral Cyanohydrin Synthesis
Introduction
Jennifer Andexer is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biochemistry, particularly in the synthesis of chiral cyanohydrins. Her innovative work has led to the development of a unique polypeptide that has garnered attention in scientific communities.
Latest Patents
Jennifer holds a patent for a method concerning the synthesis of chiral cyanohydrins via a hydroxynitrile lyase from the Brassicaceae family. This invention introduces a polypeptide that can be isolated from non-cyanogenic plants, which is a significant departure from previous assumptions that only cyanogenic plants contained hydroxynitrile lyases. The hydroxynitrile lyase of the invention is the first of its kind from the Brassicaceae family, showcasing its unique (R)-selective activity. The theoretical molecular weight of the AtHNL subunit is approximately 29.2 kDa, which is confirmed by SDS gel electrophoresis.
Career Highlights
Jennifer Andexer is currently associated with Evocatal GmbH, where she continues to advance her research and development efforts. Her work has not only expanded the understanding of hydroxynitrile lyases but also opened new avenues for the synthesis of valuable chiral compounds.
Collaborations
Jennifer collaborates with Thorsten Eggert, contributing to the innovative research environment at Evocatal GmbH. Their combined expertise enhances the potential for groundbreaking discoveries in their field.
Conclusion
Jennifer Andexer is a trailblazer in the synthesis of chiral cyanohydrins, with her patent representing a significant advancement in biochemistry. Her contributions continue to influence the scientific community and pave the way for future innovations.